Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Advanced Tissue Sciences

This article was originally published in The Gray Sheet

Executive Summary

Collaborating with Cell Genesys, Inc. on the development of a "universal, full-thickness" skin replacement product. The new product is intended to eliminate the need to harvest grafts of a patient's own skin and reduce delays associated with culturing a patient's own skin cells in the laboratory before grafting takes place. The collaboration will utilize ATS' dermal tissue engineering technology and Cell Genesys' engineered epidermal skin cells. ATS currently is in clinical trials with its Dermagraft skin replacement product for the treatment of severe burns and chronic skin ulcers....
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT000036

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel